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To the Editor
In the Case Record discussed by Biddinger et al. (Sept. 10 issue),1 the authors describe the 
care of a febrile traveler who was returning from an area in which malaria is highly endemic 
and who was considered to be in the “low (but not zero) risk category” for Ebola virus 
disease (EVD).2 Modifications made to safely assess the patient for EVD are reported, 
including the use of only a rapid diagnostic test to diagnose malaria. The Centers for Disease 
Control and Prevention (CDC) recommends immediate microscopy of thin and thick blood 
smears for the diagnosis of malaria, which can be safely performed by observing precautions 
against the transmission of EVD.3 Diagnosis by means of microscopy allows for the 
identification of species and the quantification of parasitemia, both of which are needed to 
determine the most appropriate treatment. Microscopy must always be performed after a 
rapid diagnostic test in order to confirm the result and obtain this additional information.4 
The patient discussed could have had undiagnosed hyperparasitemia, which requires 
parenteral therapy. In addition, without identifying the species by means of microscopy or 
polymerasechain-reaction assay, the authors may have missed a mixed infection, which 
could have been treated with primaquine, thereby preventing a 6-week relapse. Correct 
determination of the initial infecting species is preferred over the reliance on knowledge of 
the geographic distribution of species that cause relapsing malaria and the use of empirical 
therapy with primaquine.
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